Chaetocin treatment has been shown to extend the lifespan of progeria mice by sequestering prelamin A in the nuclear envelope and has been suggested as a treatment modality to slow down the progerin-induced aging process (Wang et al., 2024). The gene discussed is LMNA; the disease is progeroid syndrome.